Copertina

Migraine is a disorder of function: No evidence for structural alterations within the central nervous system in migraine

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Jan Mehnert, Adrian Scutelnic
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Headache: The Journal of Head and Face Pain
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Navigating the patient journey in migraine prevention: An American Migraine Foundation position paper
di: Lawrence C. Newman, et al.
Pubblicazione: (2025)

Heavy metal and trace element alterations in patients during a migraine attack
di: Sevilay Vural, et al.
Pubblicazione: (2024)

A history of abuse is associated with more severe migraine‐ and pain‐related disability: Results from the American Registry for Migraine Research
di: Meesha Trivedi, et al.
Pubblicazione: (2024)

The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine
di: Rikki Mangrum, et al.
Pubblicazione: (2024)

Magnetoencephalography studies in migraine and headache disorders: A systematic review
di: Raghavan Gopalakrishnan, et al.
Pubblicazione: (2024)

The “central vein sign” to differentiate multiple sclerosis from migraine
di: Giulia Silvestri, et al.
Pubblicazione: (2025)

The association between posttraumatic stress disorder and migraine: A systematic review
di: Lucie Nitsche, et al.
Pubblicazione: (2026)

Migraine in women
di: Arathi Nandyala, et al.
Pubblicazione: (2024)

The cortical spreading depression/migraine aura hypothesis – Finally some definitive evidence
di: Andrew C. Charles, et al.
Pubblicazione: (2025)

Sustained benefits of onabotulinumtoxinA treatment in chronic migraine: An analysis of the pooled Phase 3 REsearch Evaluating Migraine Prophylaxis Therapy (PREEMPT) randomized controlled trials
di: Stephen D. Silberstein, et al.
Pubblicazione: (2024)

Genetic migraine disorders and the response to calcitonin gene‐related peptide antagonist treatment
di: Andrea M. Kuczynski, et al.
Pubblicazione: (2025)

Driving evidence to practice for management of migraine in the emergency department: A systematic approach to guideline implementation
di: Jennifer Robblee, et al.
Pubblicazione: (2026)

Long‐term evolution of white and gray matter structural properties in migraine
di: Álvaro Planchuelo‐Gómez, et al.
Pubblicazione: (2025)

Mapping the migraine: Intracranial recording of cortical spreading depression in migraine with aura
di: Graham A. McLeod, et al.
Pubblicazione: (2025)

Editorial: Migraine as a marker of maternal morbidity
di: Barlas Benkli
Pubblicazione: (2026)

Headache‐related disability as a function of migraine aura: A daily diary study
di: Delora E. Denney, et al.
Pubblicazione: (2024)

A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine ( TEAM) study
di: Gregory A. Panza, et al.
Pubblicazione: (2024)

Beyond movement: Headache in patients with functional movement disorders
di: Elena Riva, et al.
Pubblicazione: (2024)

The effect of different exercise types on migraine frequency in individuals with migraine: A pilot study
di: Yunus Emre Meydanal, et al.
Pubblicazione: (2025)

A novel de novo AP2M1 variant in a patient with attention‐deficit/hyperactivity disorder, oppositional defiant disorder, and unexpected hemiplegic migraine
di: Giuseppe D. Mangano, et al.
Pubblicazione: (2025)

A machine learning‐driven transcriptomic study reveals the key role of Romo1 in reversing central sensitization through stellate ganglion block in migraine: An interventional study based on a recurrent migraine rat model
di: Fei Yang, et al.
Pubblicazione: (2025)

2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies
di: Jennifer Robblee, et al.
Pubblicazione: (2025)

The 2023 protocol for update to acute treatment of adults with migraine in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies
di: Jennifer Robblee, et al.
Pubblicazione: (2024)

Learnings from familial visual snow syndrome: A case series
di: Laura Weichsel, et al.
Pubblicazione: (2026)

Lifestyle triggers of migraine: Sleep restriction and caffeine lower the threshold for migraine‐like responses in rats in a sex‐specific manner
di: Gabriel Camargo de Oliveira, et al.
Pubblicazione: (2026)

No association between migraine and HLA alleles in a cohort of 13,210 individuals with migraine from the Danish Blood Donor Study
di: Inga Zalia Tummoszeit, et al.
Pubblicazione: (2024)

Evaluating associations of migraine‐related vertigo
di: Nazia Karsan, et al.
Pubblicazione: (2025)

Retrofitted adult interventions aren't good enough: Why children and adolescents deserve tailored evidence‐based care for migraine in the emergency department
di: Serena L. Orr
Pubblicazione: (2026)

Migraine across the menopausal transition and beyond: A narrative review
di: Tal Friedman Korn, et al.
Pubblicazione: (2026)

Afterimage duration differs for migraine with or without aura
di: Florian Rimmele, et al.
Pubblicazione: (2025)

Validation of a Portuguese version of the four‐item Migraine Interictal Burden Scale
di: Sofia Ferrão Malheiro, et al.
Pubblicazione: (2025)

Mechanisms for mindfulness in migraine: Does catastrophizing matter?
di: Rebecca Erwin Wells, et al.
Pubblicazione: (2024)

Useful considerations for treating migraine in patients with autism
di: Sinifunanya E. Nwaobi
Pubblicazione: (2026)

Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
di: Shuu‐Jiun Wang, et al.
Pubblicazione: (2024)

Advancing toward precision migraine treatment: Predicting responses to preventive medications with machine learning models based on patient and migraine features
di: Chia‐Chun Chiang, et al.
Pubblicazione: (2024)

Early effect of onabotulinumtoxinA on EEG ‐based functional connectivity in patients with chronic migraine: A pilot study
di: Matteo Conti, et al.
Pubblicazione: (2024)

Sequential administration of peripheral nerve blocks and onabotulinumtoxinA for the treatment of chronic migraine and other headache disorders—A retrospective tolerability and safety study
di: Christopher C. Anderson, et al.
Pubblicazione: (2024)

The potential role of sleep quality in the relationship between glymphatic function and migraine frequency: Insights from a cross‐sectional study
di: Raffaele Ornello, et al.
Pubblicazione: (2025)

Effectiveness of galcanezumab versus topiramate, amitriptyline, and other select traditional oral migraine preventives with evidence of efficacy: 3‐Month results from the TRIUMPH study
di: Shivang Joshi, et al.
Pubblicazione: (2026)

Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies
di: Irina Krikova, et al.
Pubblicazione: (2024)